Inscobee., Inc. (KRX: 006490)
South Korea
· Delayed Price · Currency is KRW | Market Cap | 249.96B |
| Revenue (ttm) | 104.95B |
| Net Income (ttm) | -45.44B |
| Shares Out | 118.47M |
| EPS (ttm) | -377.40 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 16,298,299 |
| Open | 1,941.00 |
| Previous Close | 1,892.00 |
| Day's Range | 1,850.00 - 2,030.00 |
| 52-Week Range | 800.00 - 2,050.00 |
| Beta | 0.48 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 14, 2024 |
About Inscobee.
Inscobee., Inc. engages in the smart grid, mobile virtual network operator (MVNO), bio, watch, and distribution businesses in South Korea and Hong Kong. It offers power meter modems, data concentrators, and power meter solutions; and provides budget phone communication services. In addition, the company manufactures watches, and distributes cosmetics, watches, alcoholic beverages, and health food products, as well as engages in research and development of products for autoimmune diseases, targeted agents, and hair growth. Inscobee., Inc. was fo... [Read more]
Financial Performance
In 2023, Inscobee.'s revenue was 99.81 billion, an increase of 30.17% compared to the previous year's 76.68 billion. Losses were -30.18 billion, 317.3% more than in 2022.
Financial StatementsNews
Inscobee unit Apimeds US files for $11.5M US IPO
Apimeds Pharmaceuticals US (APUS), a unit of South Korea’s Inscobee, has filed for an $11.5M U.S. initial public offering. Read more here.